Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-10

Clinical Trial Update: Pregabalin as an add-on Therapy to Carbamazepine in Trigeminal Neuralgia Patients [NA]

View source ↗

Summary

This clinical trial update reports a study evaluating pregabalin as an add-on to carbamazepine for trigeminal neuralgia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbamazepine (Carbamazepine)
  • Pregabalin (Pregabalin)

Snippet

Sponsor: Postgraduate Institute of Dental Sciences Rohtak | Conditions: Trigeminal Neuralgia | NA | Status: RECRUITING